SATIVEX Trademark

Trademark Overview

On Wednesday, July 13, 2011, a trademark application was filed for SATIVEX with the United States Patent and Trademark Office. The USPTO has given the SATIVEX trademark a serial number of 85370291. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 11, 2023. This trademark is owned by G W Pharma Limited. The SATIVEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain, [neuropathic pain,] cancer pain, [multiple sclerosis, spinal cord injury, bladder disfunction, peripheral neuropathy, spasticity,] oncology, cancer symptoms[, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; plant extracts for pharmaceutical purposes]
sativex

General Information

Serial Number85370291
Word MarkSATIVEX
Filing DateWednesday, July 13, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 11, 2023
Registration Number4281416
Registration DateTuesday, January 29, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pain, [neuropathic pain,] cancer pain, [multiple sclerosis, spinal cord injury, bladder disfunction, peripheral neuropathy, spasticity,] oncology, cancer symptoms[, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; plant extracts for pharmaceutical purposes]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 11, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameG W Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE CB249BZ
GB
Party NameG W Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalisbury, Wilshire SP40JQ
GB
Party NameG W Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalisbury, Wilshire SP40JQ
GB

Trademark Events

Event DateEvent Description
Friday, August 11, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, January 29, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 28, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, August 12, 2019NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, August 12, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, August 12, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 29, 2019TEAS SECTION 8 RECEIVED
Monday, January 29, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 12, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 12, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 29, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, November 13, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 10, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 10, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 4, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 4, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 2, 2012TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, September 28, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 28, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2012NON-FINAL ACTION E-MAILED
Wednesday, March 28, 2012NON-FINAL ACTION WRITTEN
Tuesday, March 6, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 6, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 16, 2012ASSIGNED TO LIE
Thursday, February 9, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 24, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 24, 2011NON-FINAL ACTION E-MAILED
Wednesday, August 24, 2011NON-FINAL ACTION WRITTEN
Friday, August 19, 2011ASSIGNED TO EXAMINER
Monday, July 18, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 16, 2011NEW APPLICATION ENTERED

Related Keywords

sativex pain cancer pharmaceutical psychiatric illnesses symptoms neurodegenerative oncology metabolic extracts